Fig. 1: Comprehensive multi-sample lipidomic profiling in control and MCI cohorts. | Translational Psychiatry

Fig. 1: Comprehensive multi-sample lipidomic profiling in control and MCI cohorts.

From: Lipidomic signatures reveal biomarkers of mild cognitive impairment

Fig. 1: Comprehensive multi-sample lipidomic profiling in control and MCI cohorts.The alternative text for this image may have been generated using AI.

A Study design for lipidomic analysis of invasive (plasma) and non-invasive (saliva, feces) samples from healthy controls, MCI, and dementia patients. B Donut charts showing lipid class distribution in saliva, plasma, and feces of control and MCI groups. C Violin plots of saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), and polyunsaturated fatty acids (PUFAs) in control vs. MCI groups. D Bar graphs of ω-6:ω-3 PUFAs ratios in saliva, plasma, and feces. Statistical significance was determined using Ordinary two-way ANOVA with Sidak’s multiple comparison tests (***p < 0.001, p > 0.05 (ns), ns: not significant). Data are shown as mean ± standard error of the mean (SEM).

Back to article page